Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

2:29am IST
Change (% chg)

$-0.40 (-1.37%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Latest Key Developments (Source: Significant Developments)

Accelerate Diagnostics reports Q3 loss per share $0.31
Friday, 3 Nov 2017 

Nov 2 (Reuters) - Accelerate Diagnostics Inc :Accelerate Diagnostics Inc reports q3 2017 financial results.Q3 loss per share $0.31.Q3 earnings per share view $-0.32 -- Thomson Reuters I/B/E/S.  Full Article

Accelerate diagnostics submits De Novo request to FDA for phenosystem and phenotest BC kit
Monday, 11 Jul 2016 

Accelerate Diagnostics : Accelerate diagnostics submits de novo request to fda for accelerate pheno(tm) system and accelerate phenotest(tm) bc kit .Submitted de novo request for evaluation of automatic class iii designation to u.s. Fda for pheno system and phenotest bc kit.  Full Article

BRIEF-Accelerate Diagnostics says ‍on Nov 14, board increased its size to 8 members​

* Accelerate Diagnostics says ‍on Nov 14, board increased size of board to 8 members​ - SEC Filing Source text: [http://bit.ly/2iocMIO] Further company coverage: